More recently, ONX-0914 has been shown to be effective in pediatric T-ALL cases with t (4; 11) (q21; q23) chromosomal translocation that leads to the expression of MLL–AF4 fusion protein conferring poor outcome [50]. The gene discussed is AFF1; the disease is acute lymphoblastic leukemia.